Clinical Trials Directory

Trials / Completed

CompletedNCT07425509

Evaluation of a Stannous Fluoride Dentifrice for Control of Oral Malodor

A Randomized Crossover Clinical Evaluation of a Stannous Fluoride Containing Dentifrice on Oral Malodor

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
49 (actual)
Sponsor
Church & Dwight Company, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This single-center, randomized, double-blind, two-treatment crossover clinical study evaluated the safety and efficacy of a stannous fluoride-containing dentifrice compared with a sodium fluoride control dentifrice for the control of intrinsic oral malodor. Adult subjects brushed twice daily with each product during separate treatment periods following standardized wash-out periods. Oral malodor was assessed using trained organoleptic judges applying a validated Odor Intensity (OI) scale at baseline and multiple post-treatment time points.

Detailed description

This four-week, randomized, double-blind crossover study enrolled generally healthy adult subjects with qualifying intrinsic oral malodor. Following screening and an acclimation wash-out period using an ADA-accepted sodium fluoride dentifrice, subjects were randomized to one of two treatment sequences: TheraBreath® Healthy Gums Toothpaste or Crest® Cavity Protection Toothpaste. Each treatment period included supervised and at-home twice-daily brushing without tongue brushing or use of non-study oral hygiene products. Oral malodor was evaluated at baseline, 12-hour overnight, and 4- and 8-hour post-brushing time points on Day 1 and Day 7 using standardized organoleptic assessments performed by three trained judges. Safety was monitored through oral examinations and subject interviews. Treatment comparisons were analyzed using ANCOVA models appropriate for crossover designs.

Conditions

Interventions

TypeNameDescription
DRUGSodium Fluoride DentifriceComparator toothpaste (0.243% NaF)
DRUGStannous Fluoride Toothpaste (SnF)Test toothpaste (0.454% SnF)

Timeline

Start date
2024-09-09
Primary completion
2024-11-04
Completion
2024-11-04
First posted
2026-02-23
Last updated
2026-02-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07425509. Inclusion in this directory is not an endorsement.